Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8062
First IPO Date
July 25, 2000
| Name | Title | Pay | Year Born |
| Weihong Xiao | Chief Executive Officer & Chairman | 0 | 1969 |
| Jiaqiu Du | Senior Vice President & Director | 0 | 1974 |
| Ling Jiang | Senior Vice President, Accounting Supervisor & Chief Financial Officer | 0 | 1971 |
| Xi Fei Shen | Secretary of the Board | 0 | 1973 |
| Hong Shun Jin | Senior Vice President | 0 | 1976 |
| Zhiqing Yang | Senior Vice President | 0 | 1975 |
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic infections, and immunosuppression. Additionally, Hisun Pharmaceutical addresses conditions such as weight management, viral infections, tuberculosis, and offers veterinary pharmaceuticals, among other specialized medical applications. Beyond its product lines, the firm provides product consultation and contract manufacturing/research (CMO/CRO) services. Established in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in Taizhou, China.